介紹：

截至 2023 年 5 月 17 日，SARS-CoV-2 病毒導致 766,440,796 例 COVID-19 陽性病例和超過 690 萬人死亡。31 COVID-19 疫苗的開發並沒有減緩 SARS-CoV-2 病毒的傳播，因為 病毒的變異能力。 FDA 生物製品和評估研究中心主任 Peter Marks 博士及其同事在《JAMA》發表的一篇論文中表示，未來 SARS-CoV-2 病毒可能需要每年註射一次。
據我們所知，在東亞，尚不存在關於外國英語居民是否願意接種 COVID-19 疫苗的研究。 隨著全球化的發展，收集有關外國人口子集的 COVID-19 疫苗接種意願及其相關因素的信息勢在必行。 這些信息不僅對 COVID-19 大流行有用，而且對未來可能出現的任何地方病、流行病或大流行有用。

目的和方法：

本研究的目的是確定台灣講英語的外國居民對 COVID-19 疫苗的接種情況。 評估台灣講英語的外國居民每年接受 COVID-19 疫苗接種的意願。 為了研究與接受假設的每年一次的 COVID-19 疫苗的意願相關的因素，包括社會人口特徵、接受每年一次的 covid-19 疫苗的動機、對每年一次的 COVID-19 疫苗的想法和感受，以及外國英語中接種疫苗的結構性障礙 - 說台灣居民。 這是一項混合方法研究，需要兩個數據收集部分、焦點小組和在線調查。

結果：

此次在線調查共有 219 名參與者。 63.1% 的參與者願意接受每年接種的 COVID-19 疫苗。 92.8% 和 65.3% 的參與者分別接種了完整的初級疫苗和加強疫苗。 發現與每年疫苗接受率顯著正相關的因素包括博士教育程度（OR = 26.4，95% CI 2.21-316）、影響（OR = 2.86，95% CI 1.09-7.50）、價值（OR = 4.22，95 % CI 1.69-10.6）並且面臨較低的結構性障礙（OR = 3.77，95% CI 1.30-10.9）。

結論：

這項研究的參與者的初級疫苗和加強疫苗接種率高於全球疫苗接種率，這可能是由於大流行期間制定的有關旅行、職業、學生身份、社交等方面的政策所致。面臨更多社會障礙的參與者接受每年一次新冠疫苗的可能性較低 -19疫苗。 在未來的健康危機中，結構性障礙應作為改進的主要領域，以促進疫苗的接種。

關鍵詞：假設每年註射一次 COVID-19、結構性障礙、價值、影響、英語、居民、5C 理論、意願、疫苗毫不猶豫、動機、思考和感受

Introduction:

The SARS-CoV-2 virus is responsible for 766,440,796 positive COVID-19 cases and more than 6.9 million deaths as of May 17th, 2023.31 The development of COVID-19 vaccines did not mitigate the spread of the SARS-CoV-2 virus, due to virus’s ability to mutate. The director of the FDA’s Center of Biologics and Evaluation Research, Dr. Peter Marks, and colleagues stated in a paper published in JAMA that the SARS-CoV-2 virus may require an annual shot in the future.
In East Asia, research on COVID-19 vaccine willingness or hesitancy of foreign English-speaking residents is non-existent, to our knowledge. With globalization on the rise, it is imperative that information concerning COVID-19 vaccine willingness and its associated factors be gathered on this subset of foreign population. This information will not only be useful for the COVID-19 pandemic, but for any endemic, epidemic, or pandemic that may present itself in the future.

Objectives and Method:

The aim of this research is to determine COVID-19 vaccine uptake among English-speaking foreign residents in Taiwan. To assess willingness to accept a yearly COVID-19 shot among English-speaking foreign residents in Taiwan. To examine factors associated with willingness to accept a hypothetical yearly COVID-19 vaccine including sociodemographic characteristics, motivation for accepting a yearly covid-19 vaccine, thoughts and feelings toward a yearly COVID-19 vaccine, and structural barriers to vaccine uptake among foreign English-speaking residents in Taiwan. This is a mix-method research that entails two data gathering components, a focus group, and an online survey.

Results:

There was a total of 219 participants I the online survey. 63.1% of the participants were willing to accept the yearly COVID-19 vaccine. 92.8% and 65.3% of participants had received the completed primary and booster vaccine, respectively. Factors found to be significantly positively associated with a yearly vaccine acceptance included PhD educational attainment (OR = 26.4, 95% CI 2.21-316), impact (OR = 2.86, 95% CI 1.09-7.50), value (OR = 4.22, 95% CI 1.69-10.6) and facing low structural barriers (OR = 3.77, 95% CI 1.30-10.9).

Conclusion:

Participants in this study had higher primary and booster vaccine uptake than global vaccine uptake possibly due to policies put in place during the pandemic concerning traveling, occupation, student status, socializing etc. Participants who faced more social barriers had lower odds of accepting the yearly COVID-19 vaccine. In a future health crisis structural barriers should be targeted as a major area of improvement to facilitate vaccine uptake.

Keywords: hypothetical yearly COVID-19 shot, structural barriers, value, impact, English-speaking, residents, 5C theory, willingness, vaccine non-hesitant, motivation, think and feel

1. Liu, Y. C., Kuo, R. L., & Shih, S. R. (2020). COVID-19: The first documented coronavirus pandemic in history. Biomedical journal, 43(4), 328-333. https://www.sciencedirect.com/science/article/pii/S2319417020300445
2. ProMED. (2019). Undiagnosed pneumonia–China (Hubei): Request for information. ProMED International Society for Infectious Diseases. https://promedmail.org/promed-post/?id=6864153
3. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of medicine. https://www.nejm.org/doi/10.1056/NEJMoa2001017?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov
4. Center for Disease Control and Prevention. (2021, November 4). Basics of COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/your-health/about-covid-19/basics-covid-19.html
5. Center for Disease Control and Prevention. (2017, December 6). Severe Acute Respiratory Syndrome (SARS). https://www.cdc.gov/sars/index.html
6. Moore, S., (2021, September 28) History of COVID-19. News Medical Life Sciences. https://www.news-medical.net/health/History-of-COVID-19.aspx
7. World Health Organization. (n.d.). Coronavirus disease (COVID-19) pandemic. https://www.who.int/europe/emergencies/situations/covid-19
8. Cyranoski, D., (2020, March 17). What China’s coronavirus response can teach the rest of the world. Nature Journal https://www.nature.com/articles/d41586-020-00741-x
9. Center for Disease Control and Prevention. (2022, April 26). What You Need to Know About Variants. COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/variants/about-variants.html
10. Center for Disease Control and Prevention. (2022, April 26). SARS-CoV-2 Variants Classifications and Definitions. COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fvariants%2Fvariant-info.html
11. GOV.UK. (2022, May 6). COVID-19 Response: Living with COVID-19. https://www.gov.uk/government/publications/covid-19-response-living-with-covid-19/covid-19-response-living-with-covid-19
12. Learning English. (2022, January 22). European Countries Consider Living with COVID-19. https://learningenglish.voanews.com/a/european-countries-consider-living-with-covid-19-/6405872.html
13. Dolgin, E., (2022, April 19). Pan-coronavirus vaccine pipeline takes form. https://www.nature.com/articles/d41573-022-00074-6#:~:text=Moderna's%20'pan%20human%20coronavirus'%20vaccine,all%20common%20colds%20in%20adults.
14. Mayo clinic staff (2023, Feb. 10). Different types of COVID-19 vaccines: How they work. https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/different-types-of-covid-19-vaccines/art-20506465
15. cdc.gov. (2023, May 12th). How vaccines work. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html
16. ACROBiosystems.com. (2021, Dec. 09). An Overview of Different COVID-19 Vaccines. https://www.acrobiosystems.com/A1374-An-Overview-of-Different-COVID-19-Vaccines.html?gclid=CjwKCAjwvpCkBhB4EiwAujULMrbXf5QL2-tcrfJlM0_nO1vsfckV2AMMptWEqkGDrGTY9u5XrmISPBoC9NEQAvD_BwE
17. Ncbi.nlm.nih.gov. (2022, July 14). A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329957/
18. Lazarus, J. V., Wyka, K., White, T. M., Picchio, C. A., Rabin, K., Ratzan, S. C., ... & El-Mohandes, A. (2022). Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nature communications, 13(1), 1-14. https://www.nature.com/articles/s41467-022-31441-x
19. Sallam, M., Al-Sanafi, M., & Sallam, M. (2022). A global map of COVID-19 vaccine acceptance rates per country: an updated concise narrative review. Journal of Multidisciplinary Healthcare, 15, 21. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760993/
20. Sallam, M. (2021). COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines, 9(2), 160. https://www.mdpi.com/2076-393X/9/2/160
21. Shakeel, C. S., Mujeeb, A. A., Mirza, M. S., Chaudhry, B., & Khan, S. J. (2022). Global COVID-19 vaccine acceptance: a systematic review of associated social and behavioral factors. Vaccines, 10(1), 110. https://www.mdpi.com/2076-393X/10/1/110
22. Kazeminia, M., Afshar, Z. M., Rajati, M., Saeedi, A., & Rajati, F. (2022). Evaluation of the Acceptance Rate of Covid-19 Vaccine and its Associated Factors: A Systematic Review and Meta-analysis. Journal of Prevention, 1-47. https://link.springer.com/article/10.1007/s10935-022-00684-1
23. Gonzales, A., Lee, E. C., Grigorescu, V., Smith, S. R., De Lew, N., & Sommers, B. D. (2021). Overview of barriers and facilitators in COVID-19 vaccine outreach. US Department of Health and Human Services. https://aspe.hhs.gov/sites/default/files/2021-08/Vaccine%20Outreach%20Research%20Report%208-27-2021%20FINAL.pdf
24. Zakar, R., Momina, A. U., Shahzad, S., Hayee, M., Shahzad, R., & Zakar, M. Z. (2022). COVID-19 Vaccination Hesitancy or Acceptance and Its Associated Factors: Findings from Post-Vaccination Cross-Sectional Survey from Punjab Pakistan. International Journal of Environmental Research and Public Health, 19(3), 1305. https://www.mdpi.com/1660-4601/19/3/1305/htm
25. Njoku, A., Joseph, M., & Felix, R. (2021). Changing the narrative: structural barriers and racial and ethnic inequities in covid-19 vaccination. International Journal of Environmental Research and Public Health, 18(18), 9904. https://www.mdpi.com/1660-4601/18/18/9904/htm
26. Bolatov, A. K., Seisembekov, T. Z., Askarova, A. Z., & Pavalkis, D. (2021). Barriers to COVID-19 vaccination among medical students in Kazakhstan: Development, validation, and use of a new COVID-19 Vaccine Hesitancy Scale. Human Vaccines & Immunotherapeutics, 17(12), 4982-4992. https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1982280?needAccess=true
27. Fisk, R. J. (2021). Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health Journal, 5(1), 51-55. https://www.sciencedirect.com/science/article/pii/S2414644721000051
28. Wang, M. Y., Zhao, R., Gao, L. J., Gao, X. F., Wang, D. P., & Cao, J. M. (2020). SARS-CoV-2: structure, biology, and structure-based therapeutics development. Frontiers in cellular and infection microbiology, 10, 587269. https://www.frontiersin.org/articles/10.3389/fcimb.2020.587269/full
29. Coronavirusexplained.ukri.org. (2020, March 25). What is coronavirus? The different types of coronaviruses. UK Research and Innovation. https://coronavirusexplained.ukri.org/en/article/cad0003/
30. https://www.webmd.com/lung/coronavirus-history
31. World Health Organization. (2022, June 7). WHO Coronavirus (COVID-19) Dashboard. Retrieved June 8th, 2022, from https://covid19.who.int/
32. Jarvis, L. (2022, June 1). Covid Boosters, Like Flu Shots, Need a Yearly Booster. Bloomberg. https://www.bloomberg.com/opinion/articles/2022-06-01/covid-boosters-like-flu-shots-need-a-yearly-schedule
33. Howard, J. (2022, March 21). Could the Covid-19 Vaccine become a yearly shot? Some experts think so. CNN Health. https://edition.cnn.com/2022/03/21/health/covid-19-vaccine-annual-shot/index.html
34. Burger, L. (2022, June 29). BioNtech, Pfizer to start testing universal vaccine for coronavirus. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-pfizer-starting-testing-universal-coronavirus-vaccine-h2-2022-06-29/
35. World Health Organization. (2021). Refugees and migrants in times of COVID-19: mapping trends of public health and migration policies and practices. https://apps.who.int/iris/bitstream/handle/10665/341843/9789240028906-eng.pdf
36. Vallée-Tourangeau, G., Promberger, M., Moon, K., Wheelock, A., Sirota, M., Norton, C., & Sevdalis, N. (2018). Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: Development and validation of two short scales. Vaccine, 36(44), 6540-6545. https://www.sciencedirect.com/science/article/pii/S0264410X17310927
37. Kassianos, G., Kuchar, E., Nitsch-Osuch, A., Kyncl, J., Galev, A., Humolli, I., ... & Vallée-Tourangeau, G. (2018). Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries. Vaccine, 36(44), 6546-6552. https://www.sciencedirect.com/science/article/pii/S0264410X18302056?casa_token=GEO0lt1S2RsAAAAA:ZWlNhlnpwVIfsBdrVHrcKQCu2VXreJeQ-Ywy4-B6ETfq2sGT9_9Fe-ydAOxUTupHX2J-4lRMZA
38. Chen, I. H., Ahorsu, D. K., Ko, N. Y., Yen, C. F., Lin, C. Y., Griffiths, M. D., & Pakpour, A. H. (2021). Adapting the motors of influenza vaccination acceptance scale into the motors of COVID-19 vaccination acceptance scale: psychometric evaluation among mainland Chinese university students. Vaccine, 39(32), 4510-4515. https://www.sciencedirect.com/science/article/pii/S0264410X21007945?casa_token=dODs97kPFS8AAAAA:yGDAnC6J2n6ErdnnuosNBe1f357NRfiH0qO1-B9aBKvsQVF--BG5Escw4y96ejYAn8rJLr50Nw
39. Yeh, Y. C., Chen, I. H., Ahorsu, D. K., Ko, N. Y., Chen, K. L., Li, P. C., ... & Pakpour, A. H. (2021). Measurement invariance of the drivers of COVID-19 vaccination acceptance scale: comparison between Taiwanese and mainland Chinese-speaking populations. Vaccines, 9(3), 297. https://www.mdpi.com/2076-393X/9/3/297
40. Chen, I. H., Wu, P. L., Yen, C. F., Ullah, I., Shoib, S., Zahid, S. U., ... & Pakpour, A. H. (2022). Motors of covid-19 vaccination acceptance scale (movac-covid19s): Evidence of measurement invariance across five countries. Risk management and healthcare policy, 15, 435. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922466/
41. Ahorsu, D. K., Lin, C. Y., Chen, I. H., Ullah, I., Shoib, S., Zahid, S. U., ... & Pakpour, A. H. (2022). The psychometric properties of motors of COVID-19 vaccination acceptance scale (MoVac-COVID19S): A dataset across five regions. Data in Brief, 42, 108103. https://www.sciencedirect.com/science/article/pii/S2352340922003134
42. Alagarsamy, S., Mehrolia, S., Pushparaj, U., & Jeevananda, S. (2022). Explaining the intention to uptake COVID-19 vaccination using the behavioral and social drivers of vaccination (BeSD) model. Vaccine: X, 10, 100140. https://www.sciencedirect.com/science/article/pii/S2590136221000577
43. Thomas, K. W., & Velthouse, B. A. (1990). Cognitive elements of empowerment: An “interpretive” model of intrinsic task motivation. Academy of management review, 15(4), 666-681. https://journals.aom.org/doi/abs/10.5465/AMR.1990.4310926
44. World Health Organization. (2021). Data for action: achieving high uptake of COVID-19 vaccines: gathering and using data on the behavioural and social drivers of vaccination: a guidebook for immunization programmes and implementing partners: interim guidance, 3 February 2021 (No. WHO/2019-nCoV/vaccination/demand_planning/2021.1). World Health Organization.
45. Dudley, M. Z., Privor-Dumm, L., Dubé, È., & MacDonald, N. E. (2020). Words matter: Vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination. Vaccine, 38(4), 709-711. https://pubmed.ncbi.nlm.nih.gov/31836257/
46. Marks P, Woodcock J, Califf R. COVID-19 Vaccination—Becoming Part of the New Normal. JAMA. 2022;327(19):1863–1864. doi:10.1001/jama.2022.7469 https://jamanetwork.com/journals/jama/fullarticle/2792030?c
47. covid-19.nchc.org.tw. (2022, August 16). Vaccination. NCHC COVID-19 Dashboard. https://covid-19.nchc.org.tw/dt_002-csse_covid_19_daily_reports_vaccine_city2.php?language=en
48. who.int. (2020 December 31). Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19. World Health Organization. https://www.who.int/news-room/questions-and-answers/item/herd-immunity-lockdowns-and-covid-19
49. worldmigrationreport.iom.int. (n.d.) World Migration Report 2022. IOM UN Migration. https://worldmigrationreport.iom.int/wmr-2022-interactive/
50. Youde, Jeremy. (2020) Globalization and Health. https://books.google.com.tw/books?hl=en&lr=&id=qCCgDwAAQBAJ&oi=fnd&pg=PR5&dq=globalization+of+south+korea+and+health&ots=6uUKxHiqkE&sig=tq2jMtlpCsZcAYnnx0dD86bLO14&redir_esc=y#v=onepage&q=globalization%20of%20south%20korea%20and%20health&f=false
51. Freeman, D., Loe, B. S., Chadwick, A., Vaccari, C., Waite, F., Rosebrock, L., ... & Lambe, S. (2020). COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychological medicine, 1-15. https://www.cambridge.org/core/journals/psychological-medicine/article/covid19-vaccine-hesitancy-in-the-uk-the-oxford-coronavirus-explanations-attitudes-and-narratives-survey-oceans-ii/C30FDB5C3D87123F28E351FDAAD5351A
52. Taylor, S., Landry, C. A., Paluszek, M. M., Groenewoud, R., Rachor, G. S., & Asmundson, G. J. (2020). A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Frontiers in psychology, 11, 575950. https://www.frontiersin.org/articles/10.3389/fpsyg.2020.575950/full
53. Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020). Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine, 26, 100495. https://www.sciencedirect.com/science/article/pii/S258953702030239X?via%3Dihub
54. Rhodes, A., Hoq, M., Measey, M. A., & Danchin, M. (2021). Intention to vaccinate against COVID-19 in Australia. The Lancet Infectious Diseases, 21(5), e110. https://www.sciencedirect.com/science/article/abs/pii/S1473309920307246?via%3Dihub
55. Okai, G. A., & Abekah-Nkrumah, G. (2022). The level and determinants of COVID-19 vaccine acceptance in Ghana. Plos one, 17(7), e0270768. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0270768
56. Wang, K., Wong, E. L. Y., Ho, K. F., Cheung, A. W. L., Yau, P. S. Y., Dong, D., ... & Yeoh, E. K. (2021). Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: Repeated cross-sectional surveys. Vaccines, 9(1), 62. https://www.mdpi.com/2076-393X/9/1/62
57. West, H., Lawton, A., Hossain, S., Mustafa, A. G., Razzaque, A., & Kuhn, R. (2021). COVID-19 Vaccine Hesitancy among Temporary Foreign Workers from Bangladesh. Health Systems & Reform, 7(1), e1991550. https://www.tandfonline.com/doi/full/10.1080/23288604.2021.1991550
58. Kaufman, J., Bagot, K. L., Tuckerman, J., Biezen, R., Oliver, J., Jos, C., ... & Danchin, M. (2022). Qualitative exploration of intentions, concerns and information needs of vaccine‐hesitant adults initially prioritised to receive COVID‐19 vaccines in Australia. Australian and New Zealand Journal of Public Health, 46(1), 16-24. https://onlinelibrary.wiley.com/doi/full/10.1111/1753-6405.13184
59. Katoto, P. D., Parker, S., Coulson, N., Pillay, N., Cooper, S., Jaca, A., ... & Wiysonge, C. S. (2022). Predictors of COVID-19 vaccine hesitancy in South African local communities: The VaxScenes Study. Vaccines, 10(3), 353. https://www.mdpi.com/2076-393X/10/3/353
60. Kaufman, J., Bagot, K. L., Hoq, M., Leask, J., Seale, H., Biezen, R., ... & Danchin, M. (2021). Factors influencing australian healthcare workers’ covid-19 vaccine intentions across settings: a cross-sectional survey. Vaccines, 10(1), 3. https://www.mdpi.com/2076-393X/10/1/3
61. Krueger, R. A., & Casey, M. A. (2018). Designing and conducting focus group interviews. Unpublished paper. https://www. eiu. edu/ihec/Krueger-FocusGroupInterviews. pdf. Accessed, 11.
62. Moucheraud, C., Phiri, K., Whitehead, H. S., Songo, J., Lungu, E., Chikuse, E., ... & Hoffman, R. M. (2022). Uptake of the COVID-19 vaccine among healthcare workers in Malawi. International Health. https://academic.oup.com/inthealth/advance-article/doi/10.1093/inthealth/ihac007/6549747
63. World Health Organization. (2022, June 7). WHO Coronavirus (COVID-19) Dashboard. Retrieved September 1st, 2022, from https://covid19.who.int/
64. Klugar, M., Riad, A., Mohanan, L., & Pokorná, A. (2021). COVID-19 vaccine booster hesitancy (VBH) of healthcare workers in Czechia: National cross-sectional study. Vaccines, 9(12), 1437. https://www.mdpi.com/2076-393X/9/12/1437
65. Koh, S. W. C., Tan, H. M., Lee, W. H., Mathews, J., & Young, D. (2022). Covid-19 vaccine booster hesitancy among healthcare workers: a retrospective observational study in Singapore. Vaccines, 10(3), 464. https://www.mdpi.com/2076-393X/10/3/464
66. Rzymski, P., Poniedziałek, B., & Fal, A. (2021). Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines, 9(11), 1286. https://www.mdpi.com/2076-393X/9/11/1286
67. Pal, S., Shekhar, R., Kottewar, S., Upadhyay, S., Singh, M., Pathak, D., ... & Sheikh, A. B. (2021). COVID-19 vaccine hesitancy and attitude toward booster doses among US healthcare workers. Vaccines, 9(11), 1358.https://www.mdpi.com/2076-393X/9/11/1358
68. Al-Qerem, W., Al Bawab, A. Q., Hammad, A., Ling, J., & Alasmari, F. (2022). Willingness of the Jordanian population to receive a COVID-19 booster dose: a cross-sectional study. Vaccines, 10(3), 410. https://www.mdpi.com/2076-393X/10/3/410
69. Center for Disease Control and Prevention. (2022, August 22). Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in The United State. Vaccines and Immunizations. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html
70. Center for Disease Control and Prevention. (nd). COVID-19 Vaccination Field Guide: 12 Strategies for Your Community. Vaccination and Immunization. https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence/community.html
71. Goodman, B. (2021 April 23). Lost in Translation: Language Barrier Hinders Vaccine Access. https://www.webmd.com/vaccines/covid-19-vaccine/news/20210426/lost-in-translation-language-barriers-hinder-vaccine-access
72. taipeitimes.com. (2021, March 23). Taiwan Begins COVID-19 Vaccination. Taipei Times https://www.taipeitimes.com/News/front/archives/2021/03/23/2003754315
73. studyintaiwan.org. (2021, July 29). Taiwan includes more foreign nationals in vaccination program. https://www.studyintaiwan.org/news/content/112
74. Hill, P. L., Burrow, A. L., & Strecher, V. J. (2021). Sense of purpose in life predicts greater willingness for COVID-19 vaccination. Social Science & Medicine, 284, 114193. https://reader.elsevier.com/reader/sd/pii/S0277953621005256?token=74F58DEA6EB2F0D3A7A46331443829D8AFDAA4BBC82608DD290D6D4EA47F9603E9DA36169656645EEFEC56555DF50F5E&originRegion=us-east-1&originCreation=20220902025035
75. Wu, F., Yuan, Y., Deng, Z., Yin, D., Shen, Q., Zeng, J., ... & Sun, C. (2022). Acceptance of COVID‐19 booster vaccination based on the protection motivation theory: A cross‐sectional study in China. Journal of medical virology, 94(9), 4115-4124. https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.27825?casa_token=6McSSsVSuP8AAAAA%3AQ7Zr86Qe5NLdHNjLSrP92KUcrWj3SFxXIY_9cfiDYqHSz-JpYlQjPo5UFs77QSViKUA3iqdhoqZA-Q
76. Pacella-LaBarbara, M. L., Park, Y. L., Patterson, P. D., Doshi, A., Guyette, M. K., Wong, A. H., ... & Suffoletto, B. P. (2021). COVID-19 vaccine uptake and intent among emergency healthcare workers: a cross-sectional survey. Journal of occupational and environmental medicine, 63(10), 852. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478093/
77. Tourkmani, A. M., Bin Rsheed, A. M., AlEissa, M. S., Alqahtani, S. M., AlOtaibi, A. F., Almujil, M. S., ... & Alrasheedy, A. A. (2022). Prevalence of COVID-19 Infection among Patients with Diabetes and Their Vaccination Coverage Status in Saudi Arabia: A Cross-Sectional Analysis from a Hospital-Based Diabetes Registry. Vaccines, 10(2), 310. https://www.mdpi.com/2076-393X/10/2/310
78. Reiter, P. L., Pennell, M. L., & Katz, M. L. (2020). Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine, 38(42), 6500-6507. https://www.sciencedirect.com/science/article/pii/S0264410X20310847?casa_token=ak6SReFZNWoAAAAA:TlL7miEKXmJeABsKoBLcD8LJXUnKaIDsrCogW-Rws2fc6y0VMeRCBXxDA68EbI7orChoBFZa
79. Weitzer, J., Birmann, B. M., Steffelbauer, I., Bertau, M., Zenk, L., Caniglia, G., ... & Schernhammer, E. S. (2022). Willingness to receive an annual COVID-19 booster vaccine in the German-speaking DA-CH region in Europe: A cross-sectional study. The Lancet Regional Health-Europe, 18, 100414. https://www.sciencedirect.com/science/article/pii/S2666776222001089
80. Harada, T., & Watanabe, T. (2021). Changes in vaccine hesitancy in Japan across five months during the COVID-19 pandemic and its related factors. Vaccines, 10(1), 25. https://www.mdpi.com/2076-393X/10/1/25
81. Holder, J. (2023, March 13). Tracking Coronavirus Vaccination Around the World. https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html
82. Edouard Mathieu, Hannah Ritchie, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Joe Hasell, Bobbie Macdonald, Saloni Dattani, Diana Beltekian, Esteban Ortiz-Ospina and Max Roser (2020) - "Coronavirus Pandemic (COVID-19)". Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/coronavirus
83. Mandavilli, A. (2023, Jan 23). F.D.A. Outlines a Plan for Annual COVID-19 Booster. https://www.nytimes.com/2023/01/23/health/covid-boosters-fda.html
84. Pan, E., & Gau, E. (2023, Feb 22). Taiwan to Add Annual COVID-19 Vaccine Shots to Vaccine Schedule. https://www.taiwanplus.com/news/taiwan-news/covid-19/230222021/taiwan-to-add-annual-covid-19-shots-to-vaccine-schedule